BRIEF published on 08/01/2025 at 08:30, 4 months 3 days ago Vitruvia Medical AG Reports Half-Year Results for 2025 Half-year Results Consolidated Sales Net Loss Vitruvia Medical AG 2025 Financial Report
PRESS RELEASE published on 08/01/2025 at 08:25, 4 months 3 days ago EQS-Adhoc: Vitruvia Medical AG: Half yearly results as per June 30, 2025 Vitruvia Medical AG reports half-year results as of June 30, 2025 in line with expectations, confirming full-year forecast. Anticipates sales growth and earnings improvement Sales Growth Forecast Half-year Results Earnings Improvement Vitruvia Medical AG
BRIEF published on 05/03/2025 at 08:02, 7 months 1 day ago Vitruvia Medical AG Reports Financial Results for 2024 Revenue Growth Future Outlook Vitruvia Medical AG 2024 Annual Results Improved Earnings
PRESS RELEASE published on 05/03/2025 at 07:57, 7 months 1 day ago EQS-Adhoc: Vitruvia Medical AG: Year End results as of December 31,2024 Vitruvia Medical AG reports 2024 Year End results, with increased revenue and EBITA. Positive outlook for 2025. Details in press release Revenue 2024 Vitruvia Medical AG Year End Results EBITA
BRIEF published on 07/25/2024 at 22:03, 1 year 4 months ago Vitruvia Medical AG: Half-Year Results as of June 30, 2024 Financial Performance Half-year Results 2024 Forecast Sales Targets Vitruvia Medical AG
PRESS RELEASE published on 07/25/2024 at 21:58, 1 year 4 months ago EQS-Adhoc: Vitruvia Medical AG: Half yearly results as per June 30th, 2024 Vitruvia Medical AG reports half-year results in line with expectations for the first half of 2024, confirming full-year forecast. Positive outlook with expected sales around EUR 2.0 million Sales Forecast Earnings Half-year Results Vitruvia Medical AG
BRIEF published on 05/01/2024 at 08:41, 1 year 7 months ago Vitruvia Medical AG Announces Improved Year-End Financial Results for 2023 Financial Results Revenue Growth 2024 Outlook Vitruvia Medical AG EBITA Improvement
PRESS RELEASE published on 05/01/2024 at 08:36, 1 year 7 months ago EQS-Adhoc: Vitruvia Medical AG: Year End results as of December 31, 2023 Vitruvia Medical AG reports Year End results for 2023 with revenue and earnings growth. Financial performance overview and outlook for LT technologies for 2024 Revenue Growth Financial Performance Vitruvia Medical AG Year End Results LT Technologies
PRESS RELEASE published on 09/29/2023 at 13:15, 2 years 2 months ago Vitruvia Medical AG: Consolidated interim results as per June 30th,2023
PRESS RELEASE published on 09/29/2023 at 12:15, 2 years 2 months ago EQS-Adhoc: Vitruvia Medical AG: Consolidated interim results as per June 30th,2023
Published on 12/05/2025 at 02:35, 2 hours 51 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 26 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 21 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 26 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 56 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 35 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 1 minute ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 11 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 16 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 41 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 42 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 25 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
